Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof
    11.
    发明授权
    Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof 有权
    衍生自爱泼斯坦 - 巴尔病毒衣壳抗原的肽及其用途

    公开(公告)号:US07476498B2

    公开(公告)日:2009-01-13

    申请号:US11192070

    申请日:2005-07-29

    IPC分类号: C12Q1/70

    CPC分类号: G01N33/56994

    摘要: In the area of virus diagnosis, in particular Epstein-Barr virus (EBV) diagnosis, methods for the detection of EBV and agents suitable for this purpose are provided, including peptides which are derived from p18-VCA and permit discrimination between acute and past EBV infection.

    摘要翻译: 在病毒诊断领域,特别是EB病毒(EBV)诊断中,提供了用于检测EBV的方法和适合于此目的的试剂,包括衍生自p18-VCA的肽,并允许区分急性和过去的EBV 感染。

    Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
    12.
    发明授权
    Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines 有权
    来自博氏疏螺旋体的免疫活性蛋白质,编码它们的核酸及其在测试试剂盒和疫苗中的应用

    公开(公告)号:US06808711B2

    公开(公告)日:2004-10-26

    申请号:US10403220

    申请日:2003-03-26

    IPC分类号: A61K3902

    摘要: The present invention relates to immunologically active proteins from Borrelia burgdorferi which are present in a form which is free of other proteins derived from Borrelia burgdorferi and which exhibit the sequence of the protein 1829-22A, which has the amino acid sequence (SEQ. ID NO:1) MKKFNLIIEALFAILLTACNFGLMEETKIALESSSKDVKNKILQIKKDAE DKGVNFAAFTSSETGSKVTNGGLALREAKIQAINEVEKFLKRIEEEALKL KEHGNSGQFLELFDLLLEVLESLEPIGIKGLKDFISEEAKCNPISTSER LIEVKVQIENKMEEVKRKQNLNKERKSNKGKKKK or a part sequence therefor having at least 10 consecutive amino acids, or exhibit the sequence of the protein 1829-22B, which has the amino acid sequence (SEQ. ID NO:2) MIKYNKIILTLTLLASLLAACSLTGKARLESSVKDITNEIEKAIKEAEDA GVKTDAFTETQTGGKVAGPKIRAAKIRVADLTIKFLEATEEETITFKENG AGEDEFSGIYDLILNAAKAVEKIGMKDMTKTVEEAAKENPKTTANGIIEI VKVMKAKVENIKEKQTKNQK or part sequence thereof having at least 10 consecutive amino acids.

    Active proteins from Borrelia burgdorferi
    14.
    发明授权
    Active proteins from Borrelia burgdorferi 失效
    来自博氏疏螺旋体的活性蛋白

    公开(公告)号:US06183755B2

    公开(公告)日:2001-02-06

    申请号:US09196293

    申请日:1998-11-19

    IPC分类号: A61K3902

    摘要: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation. The Borrelia burgdorferi-specific DNA sequences can be employed for direct detection of the pathogen in patients' samples (for example by means of the PCR reaction).

    摘要翻译: 通过遗传操作在微生物中制备了来自博氏疏螺旋体的各种免疫活性蛋白质。 为此,使用合适的筛选方法从布氏疏螺旋体基因库中选择特异性DNA序列,或者通过使用选择的杂交探针的DNA扩增直接制备,并置于诱导型启动子的控制下,例如, lac启动子。 由于对表达的抗原的有效纯化方法的描述,可以以合适的方式提供蛋白质是可能的。 这些蛋白质可用于制备特异性敏感的诊断测定试剂盒。 免疫活性蛋白质的特异性组合使得精确的诊断成为可能。 此外,已经产生了单克隆抗体,并且用作用于在测试样品中或培养后直接检测病原体的试剂。 疏螺旋体异常特异性DNA序列可用于直接检测患者样品中的病原体(例如通过PCR反应)。

    Immunologically active proteins from Borrelia burgdorferi
    15.
    发明授权
    Immunologically active proteins from Borrelia burgdorferi 失效
    来自博氏疏螺旋体的免疫活性蛋白

    公开(公告)号:US06509019B1

    公开(公告)日:2003-01-21

    申请号:US09711546

    申请日:2000-11-13

    IPC分类号: A61K3902

    摘要: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation. The Borrelia burgdorferi-specific DNA sequences can be employed for direct detection of the pathogen in patients' samples (for example by means of the PCR reaction).

    摘要翻译: 通过遗传操作在微生物中制备了来自博氏疏螺旋体的各种免疫活性蛋白质。 为此,使用合适的筛选方法从布氏疏螺旋体基因库中选择特异性DNA序列,或者通过使用选择的杂交探针的DNA扩增直接制备,并置于诱导型启动子的控制下,例如, lac启动子。 由于对表达的抗原的有效纯化方法的描述,可以以合适的方式提供蛋白质是可能的。 这些蛋白质可用于制备特异性敏感的诊断测定试剂盒。 免疫活性蛋白质的特异性组合使得精确的诊断成为可能。 此外,已经产生了单克隆抗体,并且用作用于在测试样品中或培养后直接检测病原体的试剂。 疏螺旋体异常特异性DNA序列可用于直接检测患者样品中的病原体(例如通过PCR反应)。

    Immunologically active proteins from Borrelia burgdorferi
    18.
    发明授权
    Immunologically active proteins from Borrelia burgdorferi 失效
    来自博氏疏螺旋体的免疫活性蛋白

    公开(公告)号:US06753183B2

    公开(公告)日:2004-06-22

    申请号:US10289795

    申请日:2002-11-07

    IPC分类号: G01N3353

    摘要: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation. The Borrelia burgdorferi—specific DNA sequences can be employed for direct detection of the pathogen in patients' samples (for example by means of the PCR reaction).

    摘要翻译: 通过遗传操作在微生物中制备了来自博氏疏螺旋体的各种免疫活性蛋白质。 为此,使用合适的筛选方法从布氏疏螺旋体基因库中选择特异性DNA序列,或者通过使用选择的杂交探针的DNA扩增直接制备,并置于诱导型启动子的控制下,例如, lac启动子。 由于对表达的抗原的有效纯化方法的描述,可以以合适的方式提供蛋白质是可能的。 这些蛋白质可用于制备特异性敏感的诊断测定试剂盒。 免疫活性蛋白质的特异性组合使得精确的诊断成为可能。 此外,已经产生了单克隆抗体,并且用作用于在测试样品中或培养后直接检测病原体的试剂。 疏螺旋体异常特异性DNA序列可用于直接检测患者样品中的病原体(例如通过PCR反应)。

    Immunologically active PC proteins from Borrelia burgdorferi
    19.
    发明授权
    Immunologically active PC proteins from Borrelia burgdorferi 失效
    来自博氏疏螺旋体的免疫活性PC蛋白

    公开(公告)号:US06248538B1

    公开(公告)日:2001-06-19

    申请号:US08209603

    申请日:1994-03-10

    IPC分类号: G01N3353

    摘要: Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation. The Borrelia burgdorferi-specific DNA sequences can be employed for direct detection of the pathogen in patients' samples (for example by means of the PCR reaction).

    摘要翻译: 通过遗传操作在微生物中制备了来自博氏疏螺旋体的各种免疫活性蛋白质。 为此,使用合适的筛选方法从布氏疏螺旋体基因库中选择特异性DNA序列,或者通过使用选择的杂交探针的DNA扩增直接制备,并置于诱导型启动子的控制下,例如, lac启动子。 由于对表达的抗原的有效纯化方法的描述,可以以合适的方式提供蛋白质是可能的。 这些蛋白质可用于制备特异性敏感的诊断测定试剂盒。 免疫活性蛋白质的特异性组合使得精确的诊断成为可能。 此外,已经产生了单克隆抗体,并且用作用于在测试样品中或培养后直接检测病原体的试剂。 疏螺旋体异常特异性DNA序列可用于直接检测患者样品中的病原体(例如通过PCR反应)。